Correlation Between Madrigal Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Madrigal Pharmaceuticals and Blueprint Medicines
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Madrigal and Blueprint is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 2.25 times more return on investment than Blueprint Medicines. However, Madrigal Pharmaceuticals is 2.25 times more volatile than Blueprint Medicines Corp. It trades about 0.34 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.22 per unit of risk. If you would invest 20,248 in Madrigal Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 12,676 from holding Madrigal Pharmaceuticals or generate 62.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Blueprint Medicines Corp |
Madrigal Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Madrigal Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Madrigal Pharmaceuticals vs. Lyra Therapeutics | Madrigal Pharmaceuticals vs. Hookipa Pharma | Madrigal Pharmaceuticals vs. Cingulate Warrants | Madrigal Pharmaceuticals vs. SAB Biotherapeutics |
| Blueprint Medicines vs. Lyra Therapeutics | Blueprint Medicines vs. Hookipa Pharma | Blueprint Medicines vs. Cingulate Warrants | Blueprint Medicines vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |